See more : Luks Group (Vietnam Holdings) Company Limited (LKSGF) Income Statement Analysis – Financial Results
Complete financial analysis of Australian Clinical Labs Limited (ACL.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Australian Clinical Labs Limited, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- EL.En. S.p.A. (ELEAF) Income Statement Analysis – Financial Results
- Spectral MD Holdings, Ltd. (SMD.L) Income Statement Analysis – Financial Results
- NVIDIA Corporation (NVD.F) Income Statement Analysis – Financial Results
- Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS) Income Statement Analysis – Financial Results
- Meyer Burger Technology AG (MYBUF) Income Statement Analysis – Financial Results
Australian Clinical Labs Limited (ACL.AX)
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Website: https://www.clinicallabs.com.au
About Australian Clinical Labs Limited
Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 689.73M | 692.10M | 989.30M | 641.31M | 487.53M | 445.89M | 376.09M | 339.77M |
| Cost of Revenue | 442.37M | 126.08M | 207.59M | 119.59M | 402.49M | 313.89M | 265.85M | 57.68M |
| Gross Profit | 247.36M | 566.02M | 781.71M | 521.73M | 85.04M | 132.00M | 110.24M | 282.09M |
| Gross Profit Ratio | 35.86% | 81.78% | 79.02% | 81.35% | 17.44% | 29.60% | 29.31% | 83.02% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 312.67M | 297.39M | 314.00M | 249.69M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | -225.48M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 87.19M | 297.39M | 314.00M | 249.69M | 69.51M | 139.58M | 116.15M | 251.50M |
| Other Expenses | 201.83M | 10.03M | -1.07M | 3.36M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 81.55M | 514.05M | 514.03M | 416.54M | 69.51M | 139.58M | 116.15M | 306.32M |
| Cost & Expenses | 632.82M | 640.14M | 721.62M | 536.12M | 472.00M | 453.47M | 382.00M | 364.00M |
| Interest Income | 501.00K | 182.00K | 45.00K | 75.00K | 38.00K | 38.00K | 47.00K | 3.38M |
| Interest Expense | 17.04M | 3.54M | 1.34M | 10.94M | 16.57M | 3.94M | 3.65M | 0.00 |
| Depreciation & Amortization | 128.43M | 122.76M | 106.10M | 88.05M | 77.90M | 11.51M | 11.32M | 12.51M |
| EBITDA | 169.65M | 184.93M | 372.75M | 196.67M | 116.30M | 3.93M | 5.41M | -8.06M |
| EBITDA Ratio | 24.60% | 25.23% | 36.63% | 28.95% | 19.16% | 0.88% | 1.44% | -2.37% |
| Operating Income | 56.91M | 51.85M | 256.24M | 97.59M | 15.53M | -7.58M | -5.91M | -20.57M |
| Operating Income Ratio | 8.25% | 7.49% | 25.90% | 15.22% | 3.19% | -1.70% | -1.57% | -6.05% |
| Total Other Income/Expenses | -20.54M | -3.66M | -12.78M | -35.96M | 1.17M | 2.38M | -1.73M | -58.20M |
| Income Before Tax | 36.37M | 48.31M | 254.90M | 86.65M | 30.89M | -9.70M | -7.64M | -27.61M |
| Income Before Tax Ratio | 5.27% | 6.98% | 25.77% | 13.51% | 6.34% | -2.18% | -2.03% | -8.13% |
| Income Tax Expense | 12.12M | 12.27M | 76.50M | 26.26M | -10.43M | 820.00K | 1.37M | 3.58M |
| Net Income | 23.93M | 35.90M | 178.24M | 60.37M | 41.26M | -10.52M | -9.01M | -24.03M |
| Net Income Ratio | 3.47% | 5.19% | 18.02% | 9.41% | 8.46% | -2.36% | -2.40% | -7.07% |
| EPS | 0.12 | 0.18 | 0.89 | 0.40 | 0.20 | -0.05 | -0.04 | -0.12 |
| EPS Diluted | 0.12 | 0.18 | 0.88 | 0.40 | 0.20 | -0.05 | -0.04 | -0.12 |
| Weighted Avg Shares Out | 198.90M | 200.57M | 201.29M | 152.10M | 202.30M | 202.30M | 202.30M | 202.30M |
| Weighted Avg Shares Out (Dil) | 199.47M | 201.12M | 201.49M | 152.10M | 202.30M | 202.30M | 202.30M | 202.30M |
Source: https://incomestatements.info
Category: Stock Reports